Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 211

1.

Lack of CCR7 expression is rate limiting for lymphatic spread of pancreatic ductal adenocarcinoma.

Sperveslage J, Frank S, Heneweer C, Egberts J, Schniewind B, Buchholz M, Bergmann F, Giese N, Munding J, Hahn SA, Kalthoff H, Klöppel G, Sipos B.

Int J Cancer. 2012 Aug 15;131(4):E371-81. doi: 10.1002/ijc.26502. Epub 2012 Jan 11.

2.

MicroRNA-21 in pancreatic ductal adenocarcinoma tumor-associated fibroblasts promotes metastasis.

Kadera BE, Li L, Toste PA, Wu N, Adams C, Dawson DW, Donahue TR.

PLoS One. 2013 Aug 22;8(8):e71978. doi: 10.1371/journal.pone.0071978. eCollection 2013.

3.

CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway.

Zhang L, Wang D, Li Y, Liu Y, Xie X, Wu Y, Zhou Y, Ren J, Zhang J, Zhu H, Su Z.

PLoS One. 2016 Aug 9;11(8):e0158529. doi: 10.1371/journal.pone.0158529. eCollection 2016.

4.

The expression of chemokines CCL19, CCL21 and their receptor CCR7 in oral squamous cell carcinoma and its relevance to cervical lymph node metastasis.

Oliveira-Neto HH, de Souza PP, da Silva MR, Mendonça EF, Silva TA, Batista AC.

Tumour Biol. 2013 Feb;34(1):65-70. doi: 10.1007/s13277-012-0511-3. Epub 2012 Sep 14.

PMID:
22976543
5.

Chemokine axes in breast cancer: factors of the tumor microenvironment reshape the CCR7-driven metastatic spread of luminal-A breast tumors.

Weitzenfeld P, Kossover O, Körner C, Meshel T, Wiemann S, Seliktar D, Legler DF, Ben-Baruch A.

J Leukoc Biol. 2016 Jun;99(6):1009-25. doi: 10.1189/jlb.3MA0815-373R. Epub 2016 Mar 2.

6.

Association between the expression of chemokine receptors CCR7 and CXCR3, and lymph node metastatic potential in lung adenocarcinoma.

Maekawa S, Iwasaki A, Shirakusa T, Kawakami T, Yanagisawa J, Tanaka T, Shibaguchi H, Kinugasa T, Kuroki M, Kuroki M.

Oncol Rep. 2008 Jun;19(6):1461-8.

PMID:
18497951
7.

The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis.

Tutunea-Fatan E, Majumder M, Xin X, Lala PK.

Mol Cancer. 2015 Feb 10;14:35. doi: 10.1186/s12943-015-0306-4.

8.

Lymphatic spread of ductal pancreatic adenocarcinoma is independent of lymphangiogenesis.

Sipos B, Kojima M, Tiemann K, Klapper W, Kruse ML, Kalthoff H, Schniewind B, Tepel J, Weich H, Kerjaschki D, Klöppel G.

J Pathol. 2005 Nov;207(3):301-12.

PMID:
16161179
9.

Expression of chemokine receptor CCR7 is associated with cervical lymph node metastasis of oral squamous cell carcinoma.

Shang ZJ, Liu K, Shao Z.

Oral Oncol. 2009 Jun;45(6):480-5. doi: 10.1016/j.oraloncology.2008.06.005. Epub 2008 Aug 26.

PMID:
18752985
10.

CCR7 regulates Twist to induce the epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma.

Li K, Xu B, Xu G, Liu R.

Tumour Biol. 2016 Jan;37(1):419-24. doi: 10.1007/s13277-015-3819-y. Epub 2015 Jul 29.

PMID:
26219899
11.

CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells.

Takeuchi H, Fujimoto A, Tanaka M, Yamano T, Hsueh E, Hoon DS.

Clin Cancer Res. 2004 Apr 1;10(7):2351-8.

12.

Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma.

Wiley HE, Gonzalez EB, Maki W, Wu MT, Hwang ST.

J Natl Cancer Inst. 2001 Nov 7;93(21):1638-43.

PMID:
11698568
13.

Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy.

Wang J, Seethala RR, Zhang Q, Gooding W, van Waes C, Hasegawa H, Ferris RL.

J Natl Cancer Inst. 2008 Apr 2;100(7):502-12. doi: 10.1093/jnci/djn059. Epub 2008 Mar 25.

PMID:
18364504
14.

Alternatively spliced tissue factor contributes to tumor spread and activation of coagulation in pancreatic ductal adenocarcinoma.

Unruh D, Turner K, Srinivasan R, Kocatürk B, Qi X, Chu Z, Aronow BJ, Plas DR, Gallo CA, Kalthoff H, Kirchhofer D, Ruf W, Ahmad SA, Lucas FV, Versteeg HH, Bogdanov VY.

Int J Cancer. 2014 Jan 1;134(1):9-20. doi: 10.1002/ijc.28327. Epub 2013 Jul 27.

15.

Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.

Jin A, Xu Y, Liu S, Jin T, Li Z, Jin H, Lin L, Lin Z.

Exp Mol Pathol. 2014 Feb;96(1):54-60. doi: 10.1016/j.yexmp.2013.11.003. Epub 2013 Nov 18.

PMID:
24263054
16.

Expression and function of the chemokine receptor CCR7 in thyroid carcinomas.

Sancho M, Vieira JM, Casalou C, Mesquita M, Pereira T, Cavaco BM, Dias S, Leite V.

J Endocrinol. 2006 Oct;191(1):229-38.

17.

Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.

Mees ST, Mardin WA, Sielker S, Willscher E, Senninger N, Schleicher C, Colombo-Benkmann M, Haier J.

Ann Surg Oncol. 2009 Aug;16(8):2339-50. doi: 10.1245/s10434-009-0531-4. Epub 2009 May 28.

PMID:
19475450
18.

Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.

Von Marschall Z, Scholz A, Stacker SA, Achen MG, Jackson DG, Alves F, Schirner M, Haberey M, Thierauch KH, Wiedenmann B, Rosewicz S.

Int J Oncol. 2005 Sep;27(3):669-79.

PMID:
16077915
19.

ACKR4 on Stromal Cells Scavenges CCL19 To Enable CCR7-Dependent Trafficking of APCs from Inflamed Skin to Lymph Nodes.

Bryce SA, Wilson RA, Tiplady EM, Asquith DL, Bromley SK, Luster AD, Graham GJ, Nibbs RJ.

J Immunol. 2016 Apr 15;196(8):3341-53. doi: 10.4049/jimmunol.1501542. Epub 2016 Mar 14.

20.

[Expression of CCR6 and CCR7 in laryngeal squamous cell carcinoma].

Chen B, Lu L, Tao L, Zhou L, Li S, Zhu L.

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2010 Nov;24(21):975-9. Chinese.

PMID:
21261017

Supplemental Content

Support Center